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Selective Depression of Low±Release Probability
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role in active signaling, sodium action potentials them-
selves have received little attention as potential regula-
tors of synaptic efficacy, likely because of the perceived
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all-or-none nature of action potentials.Washington University School of Medicine
One perplexing observation linking sodium channelsSt. Louis, Missouri 63110
(NaChs) to synaptic output comes from a class of anti-
convulsant, neuroprotective agents that reportedly in-
hibits glutamate release selectively over release of other
Summary neurotransmitters (Leach et al., 1986, 1991; Martin et
al., 1993; MacIver et al., 1996). Among the best known
Sodium channels (NaChs) play a central role in action and clinically useful compounds are riluzole (2-amino-
potential generation and are uniquely poised to influ- 6-trifluoromethoxybenzothiazole), lamotrigine, and phe-
ence the efficacy of transmitter release. We evaluated nytoin. These agents are structurally diverse and have
the effect of partial NaCh blockade on two aspects of several reported targets, but the drugs share the ability
synaptic efficacy. First, we evaluated whether NaCh to block voltage-gated sodium currents (Taylor and Mel-
blockade accounts for the ability of certain drugs to drum, 1995). It is unclear how inhibition of a ubiquitous
selectively depress glutamate release. Second, we target like voltage-gated NaChs might cause selective
evaluated the contribution of NaChs to intraneuronal glutamate release inhibition. Thus, some have ques-
variability in glutamate release probability (pr). The anti- tioned the ability of these agents to preferentially de-
glutamate drug riluzole nearly completely depresses press glutamate release (Taylor and Meldrum, 1995;
glutamate excitatory postsynaptic currents (EPSCs) at Umemiya and Berger, 1995; Obrenovitch, 1998).
concentrations that barely affect GABAergic inhibitory On the other hand, the ubiquity of NaChs may belie
postsynaptic currents (IPSCs). NaCh inhibition ex- subtle differences in density and/or functional proper-
plains the selective depression. Unlike other presyn- ties of the channels that could produce variability in
aptic depressants, partial NaCh blockade increases synaptic output between neurons and among different
paired-pulse EPSC depression. This result is explained synapses of the same neuron. Indeed, dendritic NaCh
by selective depression of low-pr synapses. We con- density is substantially higher in hippocampal interneu-
clude that local variations in the action potential con- rons than in principal cells (Martina et al., 2000). In addi-
tribute to pr variability among excitatory synapses. tion, there are differences in the density and functional
properties of various voltage-gated ion channels, including
NaChs, within individual hippocampal neurons (MageeIntroduction
and Johnston, 1995; Colbert and Johnston, 1996; Mar-
tina and Jonas, 1997; Stuart et al., 1997). Thus, althoughSynaptic transmission is a multistep process in which
sodium action potentials are generally considered all-sodium action potentials propagate along the axon to
or-none events, the inactivation status or the local den-synaptic terminals, resulting in Ca21 influx through volt-
sity of voltage-gated channels could influence synapticage-gated Ca21 channels and exocytosis of transmitter-
effectiveness by altering the action potential waveformfilled vesicles. Recently, it has become clear that the
in different branches of the axon or by promotingeffectiveness of synaptic transmission in response to
branchpoint failure. Consistent with this idea, recentaction potentials is variable. Large differences in synap-
results have suggested that the synaptic release proba-
tic output are seen not only between different types of
bility (pr) covaries more strongly in adjacent synapticneurons (Msghina et al., 1998) but also between individ-
terminals than in physically distant ones (Murthy et al.,
ual synapses of the same neuron (Atwood, 1967; Murthy 1997).
et al., 1997). There is widespread debate over the poten- Here, we examine two aspects of NaChs' potential
tial factors for governing the efficacy and variability of role in governing and modulating synaptic transmitter
synaptic transmission in the nervous system. Most re- release. First, we evaluate whether NaCh blockade can
ports examining the factors underlying variability of account for the putative ability of certain drugs to selec-
transmitter release have focused on the components of tively depress glutamate release over release of the ma-
the transmitter release machinery at the active zone. jor inhibitory neurotransmitter GABA (Leach et al., 1986,
These factors include density and open probability of 1991; Martin et al., 1993; MacIver et al., 1996). Second,
Ca21 channels at the active zone (Msghina et al., 1999), we evaluate whether local variation in NaCh function
the size of the readily releasable pool of vesicles (Murthy might participate in the recently observed variability in
et al., 1997), and the sensitivity of the release machinery vesicular glutamate pr at different synaptic terminals of
to Ca21 (Hsu et al., 1996; Johannes et al., 1998). Surpris- an axon (Rosenmund et al., 1993; Murthy et al., 1997).
ingly, despite their ubiquity in neurons and their central Our results suggest that NaCh inhibition is responsible
for the selective depression of glutamate release by anti-
glutamate drugs and suggest fundamental differences* To whom correspondence should be addressed (e-mail: menneris@
in the efficacy of excitation/secretion coupling betweenpsychiatry.wustl.edu).
excitatory and inhibitory neurons. In addition, our results² Present address: Department of Molecular and Cellular Physiol-
ogy, Stanford University, Stanford, California 94305. suggest that the excitatory postsynaptic current (EPSC)
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Figure 1. The Putative Selective Glutamate
Release Inhibitor Riluzole Preferentially De-
presses EPSCs
(A) Autaptic AMPA receptor±mediated EPSC
from a solitary excitatory neuron in the pres-
ence and absence of riluzole. Fast initial tran-
sients represent capacitive and ionic currents
in response to stimulation and have been
truncated in this and subsequent figures.
When 20.0 mM riluzole was included in the
bath solution, the EPSC was severely de-
pressed but recovered by the next stimulus,
delivered in control saline 20 s later.
(B) Autaptic GABAA receptor±mediated IPSC
from a solitary GABAergic cell. The same ex-
perimental protocol used for the cell in (A)
produced only very mild depression of the
peak IPSC, with a slight slowing of the IPSC
decay.
(C) Summary of the effects of 20.0 mM riluzole
on peak PSCs in 10 excitatory neurons and
15 inhibitory neurons.
(D) Riluzole has no significant postsynaptic
effects on AMPA receptors. Kainate (50.0 mM)
was applied to a hippocampal neuron for the
duration indicated by the bar. During the pe-
riod indicated by the closed bar, 20.0 mM rilu-
zole was coapplied to the cell with kainate.
(E±G) TTX shows differential effects quantita-
tively similar to those of riluzole.
(E) Effect of 30.0 nM TTX on an autaptic EPSC.
(F) TTX had little effect on the peak amplitude
of an autaptic IPSC and no effect on the IPSC
time course.
(G) Summary of the effects of 30.0 nM TTX
on five EPSCs (closed bar) and five IPSCs
(open bar).
(H) Summary of the effects of altering Ca21
influx on EPSCs (closed bar) and IPSCs (open
bar). Extracellular Ca21 was lowered from 2.0
mM to 1.5 mM. Extracellular Mg21 was raised
from 1.0 mM to 1.5 mM.
depression by partial NaCh blockade selectively targets experiments is that indirect effects of the drug via poly-
low-pr synapses. These results imply that local varia- synaptic modulatory circuits cannot be ruled out as a
tions in the action potential waveform may participate possible a mode of action of this drug. Hence, we tested
in dictating pr at individual synaptic terminals by shaping the idea that riluzole selectively and directly depresses
the degree of local excitation. excitatory neurotransmission. We used solitary postna-
tal hippocampal cells grown in microcultures for these
experiments. Two important advantages of this experi-Results
mental preparation for the present studies are the forma-
tion of autapses (self synapses) in microculture neurons,Selective Depression of Excitatory Neurotransmission
allowing the transmitter phenotype of neurons to beby a Presynaptic Mechanism
readily identified, and the lack of polysynaptic influencesPrevious studies reporting preferential depression of
on solitary microculture neurons. In solitary excitatoryglutamate release were based on measurements of glu-
cells, the putative anti-glutamate drug riluzole (20.0 mM)tamate and GABA in hippocampal slices (Martin et al.,
1993; MacIver et al., 1996). A disadvantage in these dramatically reduced the peak of the AMPA receptor±
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mediated autaptic EPSC (85% 6 4%, n 5 10; Figure
1A). Similar effects were observed on NMDA receptor±
mediated EPSCs examined in Mg21-free extracellular
saline (see below). In contrast, 20.0 mM riluzole inhibited
peak autaptic inhibitory postsynaptic currents (IPSCs)
in the same cultures by only 24% 6 7% (n 5 15 cells).
Riluzole slightly but reliably prolonged IPSCs (Figure
1B). The 10%±90% decay time of IPSCs increased from
121 6 15 ms to 156 6 16 ms in 20.0 mM riluzole (p ,
0.001, n 5 14 cells, paired t test). Although the prolonga-
tion of IPSCs by riluzole may contribute to the neuropro-
tective properties of riluzole, we did not further charac-
terize this effect of riluzole in the present work. Rather,
we explored the mechanism of EPSC inhibition by ri-
luzole.
To explore whether riluzole blocks postsynaptic gluta-
mate receptors, thus preferentially depressing EPSCs,
we examined neuronal responses to exogenous kainate
and NMDA to directly activate non-NMDA and NMDA
receptors, respectively (Figure 1D). Riluzole had no ef-
fect on kainate responses (0.0% 6 0.2% change, n 5 7
cells) or NMDA responses (1.5% 6 1% riluzole-induced
increase in responses to 20.0 mM NMDA, n 5 4 neurons).
Therefore, in hippocampal neurons, the preferential inhi-
bition of EPSCs by riluzole cannot be explained by de-
pression of postsynaptic receptor responsiveness.
Figure 2. Effect of Riluzole on Glutamate Release in the Absence
of Sodium Action PotentialsDepression of Sodium Current Explains Selective
The data in (A) and (B) are from one excitatory cell. The data in (C)EPSC Depression
are from another excitatory neuron.Riluzole has been reported to have multiple effects
(A) Riluzole (20.0 mM) severely depressed the EPSC, and 500 nM
on ion channels, including inhibition of voltage-gated TTX totally abolished the EPSC in response to the standard stimulus
NaChs (Hebert et al., 1994; Song et al., 1997; Stefani et protocol. In this expanded trace, the sodium current in response to
stimulation is apparent. TTX nearly abolished the sodium currental., 1997). In hippocampal microcultures, axonal escape
(arrow), while a sizable sodium current was present in the presencefrom voltage clamp and a resulting action potential are
of riluzole.necessary for effective stimulation of evoked transmitter
(B) In the presence of 500 nM TTX, autaptic transmission from un-release (Bekkers and Stevens, 1991). Therefore, action
clamped synaptic terminals was stimulated with hyperkalemic saline
potentials and, specifically, NaChs are plausible targets (104 mM potassium, equimolar substitution for sodium) applied for
for presynaptic modulators in this preparation. To evalu- the duration indicated by the thick line above the traces. The middle
trace was obtained in the presence of 20.0 mM riluzole. The traceate whether riluzole's synaptic effects are due to depres-
on the far right was obtained in the presence of 5.0 mM NBQX tosion of NaCh function, we compared them with the ef-
confirm that the transient current in response to hyperkalemia isfects of dilute tetrodotoxin (TTX), a highly selective
due to activation of glutamate receptors.inhibitor of voltage-gated NaChs. Preliminary experi-
(C) The GABAb agonist baclofen (20.0 mM) depressed the hyperka-ments showed that 30.0 nM TTX yielded EPSC inhibition lemia-induced EPSC.
similar to that of 20.0 mM riluzole, the concentration
used in the experiments described in Figures 1A±1C. drugs suggests that inhibitory and excitatory hippocam-
Surprisingly, we found that this TTX concentration pro- pal neurons differ fundamentally in the efficacy of excita-
duced preferential depression of excitatory neurotrans- tion/secretion coupling. Although each of these drugs
mission essentially identical to that of riluzole. These (with the exception of TTX) has reported targets other
results are summarized in Figures 1E±1G. Saturating than voltage-gated NaChs (Taylor and Meldrum, 1995),
concentrations of TTX (1.0 mM) abolished both EPSCs taken together with the effects of TTX, the results
and IPSCs (data not shown), consistent with the neces- strongly suggest that inhibition of NaChs accounts for
sity of sodium action potentials for transmitter release the preferential anti-glutamate effect of these drugs.
from both cell types. Riluzole did not affect somatic voltage-gated Ca21
We also evaluated the effects of three other NaCh channels, voltage-gated K1 channels, or resting K1 con-
blockers at moderate concentrations on glutamate and ductances (data not shown). In addition, the size of the
GABA neurons (n 5 7 and 6 neurons, respectively). readily releasable vesicle pool was not affected, as
Lamotrigine (10.0 mM) depressed AMPA receptor± judged from the integrated postsynaptic responses to
mediated EPSCs by 40% 6 10% and IPSCs by 1% 6 600 mM sucrose applications (data not shown). Thus,
1%. Carbamazepine (50.0 mM) depressed EPSCs by in hippocampal neurons, voltage-gated NaChs appear
40% 6 10% and IPSCs by 9% 6 7%. Phenytoin (2.5 to be the primary, if not the only, target responsible
mM) depressed EPSCs by 30% 6 8% and IPSCs by for the synaptic effects of riluzole at low micromolar
concentrations.1% 6 1%. The preferential anti-glutamate effect of these
Neuron
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3A). Despite the larger effect of TTX on sodium current,
in these same neurons, EPSC amplitude was much more
severely depressed by 20.0 mM riluzole than by 20 nM
TTX (85% 6 4% versus 43% 6 9%; Figures 3A and 3B).
We reasoned that this result could be reconciled with
the conclusion that riluzole's relevant targets are volt-
age-gated NaChs by hypothesizing that axonal NaChs
are more sensitive to riluzole than are soma NaChs.
Higher sensitivity of axon NaChs to riluzole could arise
from previously described differences in the mecha-
nisms of riluzole and TTX block. TTX is a voltage-inde-
pendent blocker of sodium current (Taylor and Meldrum,
1995), whereas riluzole is voltage dependent and may
act through binding tightly to inactivated NaChs (Hebert
Figure 3. Riluzole Produces a Paradoxically Large EPSC Depres-
et al., 1994). Consistent with these previous results, insion Based on the Amount of Soma Sodium Current Block
nucleated patches excised from the soma of excitatory
(A) Unsubtracted sodium currents recorded during synaptic stimula-
neurons, 20.0 mM riluzole shifted the steady-state inacti-tion of an excitatory neuron. TTX (20.0 nM) produced slightly greater
vation curve of sodium currents to more hyperpolarizedinhibition of the sodium current than did 20.0 mM riluzole.
potentials (Figures 4A and 4B). Boltzmann fits to steady-(B) Same trace as (A), but a longer sweep is displayed to show
the EPSC evoked in the various experimental conditions. Note that state inactivation data from excitatory neurons sug-
despite the greater inhibition of sodium current by TTX (A), the EPSC gested a shift in V1/2 (half inactivation voltage) of inactiva-
is much more severely depressed by riluzole. tion from 256 mV to 269 mV. Slope factor was 8.9 in
control conditions and 10.3 in riluzole. Similar results
were observed in nucleated patches excised from inhibi-To further determine if events related to calcium influx
tory neurons (Figure 4C). The V1/2 shift in inactivation inand exocytosis underlie the difference in susceptibility
inhibitory neurons was from 260 mV to 271 mV. Theof glutamate versus GABA-releasing neurons, we evalu-
slope factor of the Boltzmann fit was 7.4 in control condi-ated the effect of lowering extracellular [Ca21] on GABA
tions and 7.3 in riluzole. In addition to demonstratingand glutamate release. There was no difference in the
the voltage dependence of riluzole block, these datasensitivity of the two cell types to reduced Ca21 influx
suggest a similar sensitivity of GABAergic and gluta-(Figure 1H). Therefore, differences between cells in the
matergic NaChs to riluzole, at least at the soma.coupling of Ca21 influx to transmitter release do not
Higher sensitivity of the axonal NaChs to riluzoleunderlie the preferential effect of partial NaCh block on
within glutamatergic cells could arise if the resting po-EPSCs. This experiment is also consistent with the idea
tential of unclamped axon is depolarized relative to thethat riluzole's preferential effects are through an alter-
clamp potential imposed at the cell body (270 mV). Thisation of the sodium action potential rather than through
would increase the number of inactivated NaChs anda direct effect on Ca21 influx.
would render axon channels more sensitive to riluzoleIf riluzole's preferential depression of EPSCs is ex-
than to TTX. While the axon membrane potential cannotplained by NaCh blockade, then riluzole should not af-
be directly controlled, we provided a relative hyperpolar-fect EPSCs evoked by action potential±independent
ization to distal presynaptic elements with strongstimuli. In the same neurons in which riluzole severely
hyperpolarizing prepulses applied to the soma beforedepressed the electrically evoked EPSC (Figure 2A), we
presynaptic stimulation (Figures 4D and 4E). The hyper-used hyperkalemic solutions (104 mM KCl equimolar
polarizing steps did not affect the baseline EPSC ampli-substitution for NaCl) in the presence of high concentra-
tude. However, consistent with the idea that the para-tion of TTX (500 nM) to directly depolarize unclamped
doxically strong synaptic riluzole effect may relate toaxon terminals and evoke glutamate release (Figure 2B).
larger fractional block of axonal sodium current, hyper-Riluzole did not depress the peak hyperkalemia-induced
polarization relieved a large fraction of riluzole-inducedEPSC in the presence of TTX (114% 6 6% of control,
EPSC depression (Figure 4D). In contrast, EPSC inhibi-n 5 5 cells). In the same experimental protocol, another
tion by TTX was unaffected by the prepulse (Figure 4E).presynaptic modulator, the GABAB agonist baclofen, de-
These results confirm the voltage dependence of riluzolepressed peak hyperkalemia-induced release by 22% 6
and the voltage independence of TTX block of axon4% (n 5 8; Figure 2C). These results again exclude an
NaChs.effect of riluzole on postsynaptic AMPA receptors and
Similar results were obtained by removing extracellu-are consistent with the idea that NaChs are the relevant
lar potassium to hyperpolarize unclamped distal presyn-presynaptic targets of riluzole.
aptic elements. Decreasing potassium from 4.0 mM to
0.0 mM hyperpolarized the resting potential of neuronalRiluzole's Voltage-Dependent Blockade of NaChs
cell bodies from 260 6 3 mV to 271 6 5 mV (n 5 14Enhances Its Depression of EPSCs
neurons). Removal of potassium had no overall effectOne initially paradoxical aspect of the conclusion that
on the baseline EPSC amplitude (97% 6 5% change,riluzole acts exclusively through effects on NaChs was
n 5 20 neurons) but diminished the depression inducedapparent when effects of riluzole and TTX on soma so-
by 20.0 mM riluzole (79% 6 4% riluzole depression indium current were compared with the effects on EPSCs.
4.0 mM K1, 48% 6 6% riluzole depression in 0.0 mMWe found that 20.0 nM TTX blocked 33% 6 4% of unsub-
K1). There was a small but statistically significant trendtracted soma sodium current in excitatory neurons,
while 20.0 mM riluzole blocked 21% 6 4% (n 5 10; Figure toward increased block by TTX block of EPSCs upon
Sodium Channel Block and Transmitter Release
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Figure 4. Voltage Dependence of Riluzole Block Can Explain the Paradoxically Large Synaptic Depression
(A) TTX-subtracted sodium currents from a nucleated patch excised from an excitatory neuron.
(Left) Traces represent currents obtained by pulsing the membrane potential to 110 mV from prepulse potentials of 2110, 280, 250, and
220 mV in control saline (largest to smallest currents).
(Right) Same series in the presence of 20.0 mM riluzole. Note the lack of effect on sodium currents elicited from the most negative prepulse
potentials.
(B) Steady-state inactivation curves obtained from nucleated patches excised from five excitatory neurons. Current size in each patch was
normalized to the current elicited from the 2110 mV prepulse. Solid lines represent a Boltzmann fit to the steady-state inactivation data (see
Results for fit parameters). The form of the Boltzmann equation was y 5 1/(1 1 exp[(V1/2 2 V)/k]), where y is the relative response magnitude,
V1/2 is the half inactivation voltage, V is the prepulse potential, and k is the slope factor.
(C) The same protocols described in (A) and (B) were used to examine the sensitivity of NaChs in inhibitory neurons to riluzole block (n 5 5
patches; see Results for fit parameters).
(D and E) Reduction of riluzole block by hyperpolarizing prepulses.
(D1) Riluzole (20.0 mM) caused nearly complete depression of an EPSC using the standard stimulation protocol. TTX (30.0 nM) caused slightly
less block of the EPSC.
(D2) In the same neuron, a hyperpolarizing prepulse to 2100 mV was applied for 100 ms before the depolarizing stimulus was applied.
Following the depolarization, the membrane potential was returned to the standard holding potential of 270 mV so that the driving force on
postsynaptic ion channels was not altered from that of the standard protocol. Note that the riluzole effect on the EPSC was reduced, whereas
the TTX effect was not. The size of the baseline EPSC was not appreciably altered by the hyperpolarizing prepulse.
(E) Summary data from excitatory cells stimulated with the protocol in D1 (closed bars) and D2 (open bars). Effects of both riluzole (left bars,
n 5 12) and TTX (right bars, n 5 6) are depicted.
potassium removal (41% 6 8% depression in 4.0 mM the axon resting potential is more depolarized than is
the command potential at the soma.K1, 55% 6 8% depression in 0.0 mM K1, p 5 0.02, n 5
15). Although the cause of the increased TTX block is
unclear, the results, like those of Figures 4D and 4E, Evidence that NaCh Density May Partly Determine
pr during Action Potentials at Low-pr Synapsessuggest that TTX block is not reduced upon hyperpolar-
ization. Taken together, these results are consistent with We next sought to elucidate the mechanism by which
partial NaCh inhibition depresses glutamate release. Athe idea that axonal channels are more sensitive to rilu-
zole block than are somatic NaChs, possibly because common method of probing the mechanism of putative
Neuron
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In contrast to the effects of TTX and riluzole, appli-
cation of 2-chloroadenosine (1.0 mM) or a cocktail of
the metabotropic glutamate receptor agonists 1S, 3R
ACPD, and L-AP4 (50.0 mM each) decreased paired-
pulse depression at hippocampal synapses, as ex-
pected of presynaptic depressants (Mennerick and Zo-
rumski, 1995; Hashimoto and Kano, 1998; Kilbride et al.,
1998). Depression of the conditioning EPSC with these
treatments was similar to that produced by the concen-
trations of TTX or riluzole employed (Figure 5C). Thus,
the effect of partial NaCh blockade is the opposite of
that predicted by the actions of adensosine and metabo-
tropic glutamate receptor agonists.
What is a possible mechanism for the increased
paired-pulse depression during partial NaCh block? As
discussed above, an increased paired-pulse depression
suggests an increase in the mean initial pr. Individual
synapses of hippocampal neurons display a wide vari-
ability in pr (Rosenmund et al., 1993; Murthy et al., 1997).
We hypothesized that increased paired-pulse depres-
sion could result if partial NaCh blockade selectively
eliminated the contributions of low-pr synapses, leaving
contributions of high-pr synapses relatively intact. To
directly examine this idea, we took advantage of the
ability of the irreversible NMDA receptor blocker MK-Figure 5. Paired-Pulse Depression Is Increased by NaCh Blockade
801 to selectively inhibit activated NMDA receptors(A1) TTX (20.0 nM) block of EPSCs in a paired-stimulation paradigm
(Huettner and Bean, 1988). Using MK-801, previous ex-(100 ms paired-pulse interval). Control traces are thin traces; re-
sponses in the presence of TTX are thick traces. periments have distinguished at least two populations
(A2) Same traces, normalized to the control conditioning EPSC to of hippocampal synaptic terminals differing 6-fold in pr
emphasize the increase in paired-pulse depression (arrows). (Hessler et al., 1993; Rosenmund et al., 1993). High-pr(B) Summary of the effects of TTX (10±20.0 nM, n 5 8 neurons) and
synapses are preferentially susceptible to early blockriluzole (2.0 mM) on paired-pulse depression. The asterisks indicate
during repeated stimulation in the presence of MK-801,p , 0.05, paired t test. The means and standard errors associated
while low-pr synapses are blocked primarily with laterwith the bars represent the degree of conditioning EPSC depression
observed in the various conditions. stimuli (Hessler et al., 1993; Rosenmund et al., 1993).
(C) Summary of the effect of a cocktail of metabotropic glutamate Brief applications of MK-801 should reduce the contri-
receptor agonists (50.0 mM L-AP4 and 50.0 mM 1S, 3R ACPD [mGlu]) bution of high-pr synapses to EPSCs. Therefore, if partialand an adensoine receptor agonist (1.0 mM 2-chloroadenosine
NaCh blockade selectively depresses low-pr synapses,[CHA]) on paired-pulse depression of EPSCs.
then the EPSC depression due to partial NaCh blockade
should increase after MK-801 treatment.
We therefore examined EPSC block by riluzole beforepresynaptic modulators is to examine responses to
and after MK-801 treatment. Preferential block of NMDApaired presynaptic stimuli. Paired-pulse stimulation of-
receptors at high-pr synapses was induced by applyingten results in the depression of transmitter release (Mag-
three to eight synaptic stimuli in the presence of 10.0leby, 1987; Zucker, 1989). Depression results primarily
mM MK-801, an amount sufficient to reduce the EPSCfrom depletion of the readily releasable vesicle pool of
amplitude by 67% 6 4% (n 5 7). Riluzole block of NMDAvesicles and is especially prominent when the basal pr is
EPSCs increased significantly after MK-801 treatmenthigh (e.g., Mennerick and Zorumski, 1995). Presynaptic
(37% 6 3% before MK-801 to 60% 6 4% after MK-801;modulators that decrease pr also decrease depletion of
Figures 6A and 6B). In contrast, there was no significantthe releasable pool during conditioning stimulation and
difference in the amount of riluzole block of AMPA re-therefore decrease paired-pulse depression. Examples
sponses in these same cells before and after MK-801of this phenomenon can be seen in the effects of adeno-
treatment (Figures 6A and 6B), thus excluding nonspe-sine and metabotropic glutamate receptor agonists on
cific time or stimulus-dependent changes in riluzole sen-glutamatergic synapses (Hashimoto and Kano, 1998;
sitivity. Very similar results were obtained with the volt-Kilbride et al., 1998).
age-independent blocker TTX (Figure 6C). TTX blockSurprisingly, we found that application of 20.0 nM
increased from 22% 6 5% to 31% 6 4% after MK-TTX resulted in increased paired-pulse depression at a
801. This result indicates that partial blockade of NaChspaired-pulse interval of 100 ms (Figures 5A and 5B).
preferentially inhibits synaptic release from low-pr syn-Riluzole at concentrations of 2±10.0 mM also elicited
apses.very similar effects (Figure 5B). Note that increased
These results suggest that partial NaCh block maypaired-pulse depression elicited by riluzole cannot be
produce unequal effects on the sodium action potentialexplained by riluzole's use dependence (Hebert et al.,
in different synapses and therefore preferentially inhibit1994) because the voltage-independent blocker TTX
release from some synapses. However, it is also possi-caused a similar increase in paired-pulse depression
(Figures 5A and 5B). ble that partial NaCh block affects all synapses equally,
Sodium Channel Block and Transmitter Release
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but reduced Ca21 entry during NaCh block might prefer-
entially target low-pr synapses because low-pr synapse
have inherently reduced Ca21 entry or poor coupling of
Ca21 entry with exocytosis. If susceptible synapses have
inherently low pr, then synaptic depression produced by
altering Ca21 influx should also selectively target low-pr
synapses. In contrast to this prediction, we found that
synaptic depression caused by reducing [Ca21]o from
3.0 mM to 1.8 mM, although similar in magnitude to that
produced by dilute TTX or riluzole, did not significantly
increase after MK-801 treatment (Figure 6C). Thus, dif-
ferences in sodium action potentials at different syn-
apses are likely responsible for the differential effects
of partial NaCh block on release from different sites on
the same presynaptic cell.
Is the Effect on EPSCs by Partial NaCh Block
Due to Branch Failure or to Alteration
of the Action Potential Waveform?
Partial NaCh block might depress EPSCs by either of
two mechanisms. Partial NaCh block could produce
branchpoint failure by eliminating action potential inva-
sion of axon branches or synaptic terminals. Alterna-
tively, the action potential waveform may be altered in
some axonal branches or synapses, such that Ca21 in-
flux is substantially reduced at the affected synapses.
While these two possibilities are not necessarily mutu-
ally exclusive, we addressed the likely contribution of
each mechanism with the experiments depicted in Fig-
ure 7.
If branch failure is responsible for the effect of dilute
NaCh blockers on EPSCs, then decreasing (hyperpolar-
izing) action potential threshold should partially reverse
the effect of TTX. TTX (10.0 nM) increased somatic action
potential threshold by 6.1 6 0.9 mV in seven neurons
(data not shown). If the synaptic effects of TTX are pri-
marily mediated by branchpoint failure, reversing this
effect on threshold should partially compensate for the
effect of TTX on EPSCs. To manipulate action potential
threshold, we altered the concentration of divalent cat-
ions in the extracellular saline to alter surface potential
(Hille, 1992). Decreasing the divalent cation concentra-
tions from 2.0 mM Ca21 and 2.0 mM Mg21 (2±2 saline)
to 1.1 mM Ca21 and 0.0 mM Mg21 (1.1±0 saline) hyperpo-
larized action potential threshold by 5.8 6 0.3 mV with-
out altering action potential peak (0.2 6 0.2 mV change,
p . 0.05) or width (0.0 6 0.1 ms change, p . 0.05
change, n 5 5 neurons).
By decreasing both Ca21 and Mg21, we achieved con-
ditions that maintained a similar inherent pr (in the ab-
sence of action potentials), assessed by KCl-evoked
EPSCs in the presence of 500 nM TTX (Figure 7B). Con-
sistent with the similar efficacy of KCl-evoked transmit-Figure 6. Evidence that NaCh Blockade Preferentially Targets
ter release, action potential±evoked EPSCs were similarLow-pr Synapses
(A) The top traces represent AMPA receptor±mediated EPSCs; the
bottom traces represent NMDA receptor±mediated EPSCs from the
same cell. For both sets of traces, the extracellular saline contained ered. Note the change in scale of the NMDA EPSCs and the increase
3.0 mM Ca21, no added Mg21, and 10.0 mM glycine. In separate in riluzole effect after MK-801 treatment.
experiments, removing Mg21 had a relatively minor effect on isolated (B) Summary of the effect of riluzole before MK-801 treatment
AMPA EPSCs (16% 6 6% increase in EPSC, n 5 3). AMPA receptor± (closed bars) and after MK-801 treatment (open bars) on NMDA and
mediated EPSCs were isolated using 50.0 mM D-APV. NMDA EPSCs AMPA receptor±mediated EPSCs (n 5 7 neurons).
were isolated by omitting D-APV and including 1.0 mM NBQX. Thin (C) Summary of the effect before (closed bars) and after (open bars)
traces represent control EPSCs; thick traces represent EPSCs in MK-801 treatment of TTX (15.0 nM, p , 0.005, n 5 8, paired t test)
the presence of 2.5 mM riluzole. Between the left traces and right and decreased extracellular Ca21 (1.8 mM from 3.0 mM, p . 0.5,
traces, five stimuli in the presence of 10.0 mM MK-801 were deliv- n 5 7) on NMDA receptor±mediated EPSCs.
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Figure 7. Alteration of Action Potential Waveform but Not Action Potential Threshold Partially Reverses the Effect of Dilute TTX
(A) Decreasing the extracellular divalent cation concentration decreased action potential threshold but did not alter the action potential shape.
Threshold is indicated by the arrows. The numbers associated with the divalent cations represent concentrations in millimolars. See Results
for a summary of effects on action potential waveform.
(B) The same decrease in divalent cation concentration does not substantially alter transmitter release elicited by KCl. TTX (500 nM) was
present throughout. The experimental protocol was the same as that used for Figure 2. The open bar denotes the timing of the KCl application.
(C) The decrease in divalents did not alter action potential±mediated release and did not reduce the degree of TTX (10.0 nM) block of EPSCs.
(D±F) Effect of overcoming TTX effects on action potential waveform.
(D) In the presence of 120 mM Na1 and 40.0 mM choline, TTX (10.0 nM) slightly inhibited the peak of the action potential. The alteration was
overcome by increasing [Na1]o to 160 mM (and omitting choline). The dotted line indicates action potential peak in 120 mM Na1.
(E) Summary of the effect of increasing Na1 on the alterations in action potential waveform induced by 10.0 nM TTX. Differences (D) in the
graphs were obtained by subtracting the peak, width, and threshold values of action potentials in 120 mM Na1 from action potentials in the
presence of 120 mM Na1 plus TTX (10.0 nM, closed bars) and 160 mM Na1 plus TTX (10.0 nM, open bars).
(F) Effect of increased [Na1]o on postsynaptic currents. Na1 solution (160 nM) increased the response to 20.0 mM kainate (KA) by z36%
compared with responses in 120 mM Na1. Kainate application is denoted by the horizontal bar. The period during which Na1 was raised is
indicated by the shaded bar.
(G) (Left) EPSCs were similarly affected by increased Na1.
(Right) In the presence of 10.0 nM TTX, the effect of raising extracellular Na1 on EPSC amplitude was much larger, suggesting that increased
Na1 partially overcomes the effect of TTX on EPSCs.
in the 2±2 saline and 1.1±0 saline (within 7% 6 3%, n 5 should overcome the effects of dilute TTX. Raising [Na1]o
from 120 mM (plus 40.0 mM choline chloride to maintain13 cells). Importantly, despite the decrease of action
potential threshold in 1.1±0 saline, TTX-induced EPSC osmolarity and charge) to 160 mM partially reversed the
effects of 10.0 nM TTX on soma action potential heightdepression was not decreased in 1.1±0 saline (Figure
7C). In fact, the average effect of TTX was slightly in- and width (Figures 7D and 7E) but did not alter the effect
of TTX on action potential threshold (Figures 7D and 7E).creased in 1.1±0 saline from 22% 6 5% to 31% 6 7%
(p , 0.05). This result is inconsistent with action potential Raising [Na1]o by itself increased peak action potential
height by 6.3 6 0.3 mV but also decreased the actionfailure playing an important role in EPSC depression by
dilute TTX, although it does not entirely exclude it. potential width by 0.41 6 0.03 ms (p , 0.05, n 5 7
excitatory neurons).In contrast to action potential failure, if more subtle
alterations of the action potential waveform are impor- Raising Na1 by 40.0 mM increased peak control EPSCs
by 39% 6 8% (n 5 6). However, this increase was indis-tant in the synaptic effect of NaCh blockers, then a
manipulation that reverses the effect of TTX on the ac- tinguishable from the increase in exogenous kainate-
induced currents produced by raising Na1 (36% 6 4%,tion potential waveform should provide partial rescue
from effects of TTX on EPSCs. By raising the driving n 5 7 neurons; Figures 7F and 7G). Therefore, the in-
crease in EPSC amplitude with the increase in Na1 isforce on extracellular Na1 and therefore enhancing the
current through unblocked NaChs, an elevated [Na1]o accounted for by the increased driving force on Na1
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through postsynaptic receptor channels. In contrast, in (Martin et al., 1993; MacIver et al., 1996) and its reported
efficacy in treating amyotrophic lateral sclerosis, a disor-the presence of 10.0 nM TTX, the increase in EPSC with
increased Na1 was much more dramatic (200% 6 72%, der possibly involving glutamate-mediated degenera-
tion of motor neurons (Louvel et al., 1997). Previousn 5 6 neurons; Figure 7G). Thus, partially reversing the
effect of TTX on action potential waveform partially over- studies examining differential effects of riluzole on trans-
mitter release in excitatory versus inhibitory neuronscame the effect of TTX on synaptic glutamate release.
Taken together, the results of Figure 7 strongly suggest were performed in slices (Martin et al., 1993; MacIver et
al., 1996). The issue of whether glutamate release isan important role for alteration of action potential wave-
form, but not for branch failure, in the synaptic effects directly affected by riluzole was ambiguous in these
studies because of the possibility that other neuromodu-of partial NaCh block. This conclusion is also consistent
with recent studies suggesting a high safety factor for latory transmitter systems impinging on the gluta-
matergic cells might be the relevant targets of riluzole.branch invasion of CNS axons (Mackenzie and Murphy,
1998). Combined with previous results, our results with solitary
neurons clearly demonstrate that preferential depres-As a further test of the idea that action potential wave-
form alteration is important in the effect of partial NaCh sion of glutamate release is explained by a direct effect
of riluzole on glutamatergic cells.block on glutamate release, we attempted to overcome
the synaptic effect of 10.0 nM TTX with elevated extra- Riluzole may have cellular targets other than NaChs
(Debono et al., 1993; Hebert et al., 1994; Huang et al.,cellular Ca21. We reasoned that increasing the driving
force on Ca21 should overcome the effect of TTX, but 1997; Fink et al., 1998). However, in our experiments,
soma calcium currents, soma potassium currents, andonly if an action potential continues to invade suscepti-
ble synaptic terminals in the presence of TTX. The postsynaptic glutamate receptors were unaffected by
riluzole. Dilute concentrations of many different typesbranchpoint failure hypothesis, in contrast, would pre-
dict that increasing extracellular Ca21 should have no of NaCh inhibitors all exhibit similar preferential depres-
sion of EPSCs, and we detected no effect of riluzole oneffect on TTX-induced EPSC depression. Consistent
with the experiments shown in Figure 7, we found that glutamate released in the absence of sodium action
potentials. Finally, the selective NaCh blocker TTX ex-increasing Ca21 from 2.0 mM to 3.0 mM (Mg21 constant
at 1.0 mM) potentiated EPSCs by 18% 6 2% in the hibited all of the same essential effects on synaptic
responses as riluzole. Thus, NaCh inhibition is clearlyabsence of TTX but potentiated EPSCs by 45% 6 6%
in the presence of TTX (n 5 12; data not shown). In sufficient to explain the differential effect of riluzole at
low micromolar concentrations, and targets other thanthese experiments, TTX alone in 2.0 mM Ca21 depressed
EPSCs by 59% 6 6%. In summary, these results support NaChs need not be invoked to explain the anti-glutamate
properties of riluzole. Because NaCh blockers are im-the idea that partial NaCh block results in alteration of
the action potential waveform at the synapse rather than portant clinical anticonvulsants (Taylor and Meldrum,
1995), the selective anti-glutamate action of these drugsin failure of action potential invasion. These experiments
are also consistent with the idea that TTX most effec- may be an important, underappreciated anticonvulsant
mechanism.tively blocks low-pr synapses (Figures 5 and 6). Under
conditions of high pr (raised extracellular calcium in There are several possible mechanisms that may un-
derlie the differential effects of NaCh blockers on gluta-these experiments), TTX was less effective in blocking
glutamate release. mate versus GABA release. Because the voltage-inde-
pendent NaCh blocker TTX has a differential effect on
EPSCs similar to that of voltage-dependent blockers, itDiscussion
is unlikely that differences in the resting potential and
steady-state inactivation status of excitatory versus in-We provide evidence that at subsaturating concentra-
hibitory axons explain the differential depression oftions, NaCh antagonists selectively depress glutamate
EPSCs. Also, NaChs from inhibitory neurons, at least atover GABA release in hippocampal neurons. The selec-
the cell body, are not less sensitive to pharmacologicaltive depression of excitatory neurotransmission by
blockade than are channels from excitatory neuronsNaCh inhibition implies that excitatory and inhibitory
(Figure 4C). Rather, GABAergic hippocampal neuronscells differ fundamentally in the efficacy of excitation/
exhibit a fundamental difference from glutamatergicsecretion coupling. Investigation of the mechanism by
cells in the efficacy of depolarization/secretion coupling.which partial NaCh inhibition results in EPSC depression
This may arise from differences in the passive mem-strongly suggests that NaCh density or other factors
brane properties or axonal branching patterns of in-influencing the sodium action potential waveform influ-
terneurons, differences in the functional density ofence pr at excitatory synapses. These conclusions have
NaChs in interneuron axons, or differences in the func-implications for both the basic physiology of CNS syn-
apses and the mechanisms of clinically important drugs. tional coupling of sodium action potentials to calcium
influx and transmitter release.
While the precise contribution of these factors awaitsSelective Inhibition of Excitatory Neurotransmission
further study, a recent report suggested that NaCh den-by Partial NaCh Blockade
sity in the dendrites of hippocampal inhibitory interneu-NaCh inhibition evokes dramatically different effects on
rons is substantially higher than is the density in dendritesneurotransmission by excitatory and inhibitory hippo-
of cortical principal excitatory neurons (Martina et al.,campal neurons. Riluzole was chosen as a prototype
2000). Further, somatodendritic action potential propa-voltage-dependent NaCh blocker (Taylor and Meldrum,
1995) because of its reported anti-glutamate effects gation in the interneurons was fast and highly reliable,
Neuron
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and exhibited little attenuation. In contrast, action po- than do excitatory neurons. However, other factors be-
sides the sodium action potential surely participate intential propagation in cortical principal cells is slow and
unreliable, and attenuates (Stuart and Sakmann, 1994). setting pr, and these factors could play a relatively
stronger role in influencing pr at GABA synapses.This finding raises the strong possibility that the higher
safety factor for NaCh blockade in inhibitory neurons Our results indicate that partial NaCh block may pro-
duce an altered action potential waveform and therebyobserved in our study might arise from differences in
the density of axonal NaChs between inhibitory and ex- elicit less Ca21 influx. The effect of partial NaCh blockade
could not be rescued by reducing action potentialcitatory neurons.
threshold, suggesting that action potential failure is un-
likely to be a strong factor in the synaptic effects ofPreferential Inhibition of Low-pr Excitatory
dilute TTX. In contrast, increasing Ca21 influx and in-Synapses by Partial NaCh Blockade
creasing the sodium driving force to reverse the effectsAlthough synaptic release probability is of fundamental
of TTX on action potential waveform both significantlyimportance to understanding neuronal communication,
reversed the synaptic depression induced by dilute TTX.the factors influencing pr are not well understood. So-
Thus, a primary mechanism of partial NaCh block isdium action potentials may appear to be unlikely partici-
alteration of the action potential waveform.pants in setting release efficacy because of the percep-
In summary, we have shown that partial NaCh block-tion that action potentials are all-or-none phenomena.
ade has dramatically different effects on the efficacy ofHowever, regional differences in sodium action poten-
transmitter release from two major classes of hippocam-tials or in susceptibility to action potential invasion could
pal neurons and has differenct effects even at differentinfluence synaptic effectiveness at different synaptic
synapses of the same excitatory axon. A primary mecha-sites of the same axon. A particularly provocative finding
nism by which glutamate release is depressed by partialin the current work is that partial NaCh blockade prefer-
NaCh block is through alteration of the action potentialentially depresses transmitter release from low-pr syn-
waveform. These results demonstrate a strong role forapses, evidenced by increased paired-pulse depression
sodium action potentials in influencing pr and suggestin the presence of riluzole and TTX, and increased de-
an unappreciated role for NaChs in dictating the efficacypression of NMDA EPSCs after MK-801-induced sup-
of synaptic transmission.pression of high-pr synapses. Furthermore, in elevated
extracellular Ca21, which should increase average pr,
partial NaCh blockade was significantly less effective in Experimental Procedures
depressing release. The clear corollary of the finding
Hippocampal Culturesthat partial NaCh block targets low-pr synapses is that
Hippocampi were taken from albino Sprague-Dawley rat pups atthe sodium action potential, and perhaps the NaChs
postnatal day 1±3 and dissociated by papain and mechanical disper-themselves, influence pr at excitatory synapses and sion as described (Mennerick et al., 1995). Microculture plates were
have a larger role in influencing the efficacy of transmit- prepared by coating 35.0 mM plastic cultures dishes (Falcon) with
ter release than previously realized. Interestingly, the a solution of 0.15% agarose. The agarose dried to form a nonpermis-
functional density of available NaChs does not appear sive background for cell adhesion. On the agarose layer, small drop-
lets of collagen (0.5 mg/ml) were sprayed with a microatomizerto be dictated strongly by steady-state inactivation of
(Thomas Scientific). Cells were seeded on the bottom of a collagen-channels because strong hyperpolarizing prepulses and
coated culture dish at an initial plating density of 100/mm2. Cultureshypokalemic solutions, both of which diminish riluzole-
were used for electrophysiology 8±17 days following plating.
induced synaptic depression, do not increase the size
of baseline EPSCs.
ElectrophysiologyIt is possible that a factor other than NaCh density
Whole-cell recordings were obtained using pipettes with 1.5±4 MV
per se plays a critical role in shaping the sodium action open tip resistance when filled with the standard pipette solution
potential waveform in different parts of the axon. For containing (in mM): KCl, 130; NaCl, 5.0; CaCl2, 0.5; EGTA, 5.0; and
HEPES, 10.0 (pH adjusted to 7.25 with KOH). At the time of experi-instance, potassium channel density, different electro-
ments, culture medium was replaced with an extracellular recordingtonic properties of different axonal segments, and the
saline consisting of (in mM): NaCl, 138; KCl, 4.0; CaCl2, 2.0; MgCl2,size of synaptic boutons are potential factors for altering
1.0; glucose, 10.0; and HEPES, 10.0 (pH 7.25 with NaOH). Exceptthe action potential waveform, thus decreasing pr and for experiments in which NMDA receptor±mediated EPSCs were
rendering associated synapses susceptible to partial specifically examined, 25.0 mM D-APV was included in the bath
NaCh blockade. Bouton size has been correlated with solution. For examination of responses to exogenous NMDA re-
sponses, the bath solution contained 0.5 mM CaCl2, no added MgCl2,pr at hippocampal synapses, and small boutons have
10.0 mM glycine, and 5.0 mM NBQX. Other alterations to these stan-disproportionately small active zones (Schikorski and
dard solutions are given in the text and figure legends.Stevens, 1997). If NaChs in boutons are localized prefer-
Autaptic release of neurotransmitter was stimulated in voltageentially to active zones, the small number of channels
clamped solitary microculture neurons with a 2.0 ms voltage pulse
in small synapses may be unable to drive the membrane to 0 mV. Holding potential before and after the stimulus was 270
capacitance as effectively as at larger synapses. mV, except as noted. PSCs are totally eliminated with application
of saturating concentrations of TTX (1.0 mM; data not shown), sug-Note that our results do not exclude a role for the
gesting that this stimulation protocol elicits an action potential inaction potential waveform in setting pr at inhibitory syn-
the partially clamped axon of the neuron that triggers transmitterapses, but the data suggest that block of a significantly
release. Stimulation rates for all experiments were ,0.05 Hz. Threehigher fraction of NaChs is necessary to depress GABA
to six traces in each experimental condition were typically acquired
release compared with glutamate release. Our results for analysis. Control conditions were interleaved with experimental
may (but do not necessarily) predict that GABAergic conditions wherever possible to account for any time-dependent
changes in transmission. EPSCs were easily distinguished fromneurons have a higher pr in response to action potentials
Sodium Channel Block and Transmitter Release
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GABAergic IPSCs on the basis of PSC time course. Previous experi- mediated by rat kainate and NMDA receptors expressed in Xenopus
oocytes. Eur. J. Pharmacol. 235, 283±289.ments have shown that all PSCs in postnatal hippocampal microcul-
tures are either glutamatergic or GABAergic, defined by sensitivity Fink, M., Lesage, F., Duprat, F., Heurteaux, C., Reyes, R., Fosset,
to appropriate receptor antagonists (Mennerick et al., 1995). M., and Lazdunski, M. (1998). A neuronal two P domain K1 channel
For measurement of steady-state inactivation curves, nucleated stimulated by arachidonic acid and polyunsaturated fatty acids.
patches were excised from solitary microculture neurons (Sather et EMBO J. 17, 3297±3308.
al., 1992) following synaptic stimulation to identify the transmitter Hashimoto, K., and Kano, M. (1998). Presynaptic origin of paired-
phenotype of the neuron. For these experiments, the pipette solution pulse depression at climbing fibre-Purkinje cell synapses in the rat
contained cesium methanesulfonate in place of KCl to block volt- cerebellum. J. Physiol. (Lond) 506, 391±405.
age-gated potassium conductances. The extracellular solution also
Hebert, T., Drapeau, P., Pradier, L., and Dunn, R.J. (1994). Block ofcontained 100 mM Cd21 to block Ca21 conductances. The membrane
the rat brain IIA sodium channel alpha subunit by the neuroprotectivepotential was stepped from the holding potential of 270 mV to
drug riluzole. Mol. Pharmacol. 45, 1055±1060.prepulse potentials ranging from 2110 mV to 220 mV for 140 ms,
Hessler, N.A., Shirke, A.M., and Malinow, R. (1993). The probabilityfollowed by a test activation step to 110 mV. The family of voltage
of transmitter release at a mammalian central synapse. Nature 366,pulses was performed in control, riluzole (20.0 mM), and TTX (500
569±572.nM) conditions. The TTX series was digitally subtracted from the
Hille, B. (1992). Ionic Channels of Excitable Membranes (Sunderland,control and riluzole series to eliminate any remaining voltage-gated
MA: Sinauer Associates).conductances from the analyzed traces.
Data were collected using an Axoclamp 1-D patch-clamp amplifier Hsu, S.F., Augustine, G.J., and Jackson, M.B. (1996). Adaptation
(Axon Instruments, Foster City, CA) interfaced to a Digidata 1200 of Ca21-triggered exocytosis in presynaptic terminals. Neuron 17,
acquisition board and a Pentium II computer. Synaptic responses 501±512.
were sampled at 5±10 kHz. Sodium currents from nucleated patches Huang, C.S., Song, J.H., Nagata, K., Yeh, J.Z., and Narahashi, T.
were sampled at 10 kHz. The PClamp software suite (Axon Instru- (1997). Effects of the neuroprotective agent riluzole on the high
ments) was used for data acquisition and analysis. Data were plotted voltage-activated calcium channels of rat dorsal root ganglion neu-
using Sigma Plot (SPSS software). Data are presented in the text rons. J. Pharmacol. Exp. Ther. 282, 1280±1290.
and figures as mean 6 standard error.
Huettner, J.E., and Bean, B.P. (1988). Block of N-methyl-D-aspar-
Action potential waveforms in response to depolarizing current
tate-activated current by the anticonvulsant MK-801: selective bind-
injections were measured using the fast current-clamp mode of an
ing to open channels. Proc. Natl. Acad. Sci. USA 85, 1307±1311.
EPC9 amplifier. Action potential width was measured at 50% of the
Johannes, L., Lledo, P.M., Chameau, P., Vincent, J.D., Henry, J.P.,peak amplitude. Threshold was defined as the first point at which the
and Darchen, F. (1998). Regulation of the Ca21 sensitivity of exo-slope of the action potential waveform increased by four standard
cytosis by Rab3a. J. Neurochem. 71, 1127±1133.deviations over the average slope during the initial passive mem-
Kilbride, J., Huang, L.Q., Rowan, M.J., and Anwyl, R. (1998). Presyn-brane response to the depolarizing current injection.
aptic inhibitory action of the group II metabotropic glutamate recep-
tor agonists, LY354740 and DCG-IV. Eur. J. Pharmacol. 356,Chemicals and Drugs
149±157.All chemicals and solutions were from RBI/Sigma (St. Louis, MO),
Leach, M.J., Marden, C.M., and Miller, A.A. (1986). Pharmacologicalexcept for lamotrigine, which was a gift of Dr. Nuri Farber (Washing-
studies on lamotrigine, a novel potential antiepileptic drug: II. neuro-ton University). Riluzole, phenytoin, lamotrigine, and carbemazepine
chemical studies on the mechanism of action. Epilepsia 27, 490±497.were prepared as concentrated stock solutions in dimethyl sulfoxide
Leach, M.J., Baxter, M.G., and Critchley, M.A. (1991). Neurochemical(DMSO), from which working solutions were prepared. In all cases,
and behavioral aspects of lamotrigine. Epilepsia 32, S4±S8.DMSO concentration in working solutions was #0.1%. TTX and MK-
801 were prepared as a stock solution in water and diluted 100- to Louvel, E., Hugon, J., and Doble, A. (1997). Therapeutic advances in
5000-fold to achieve working concentrations. Drugs were applied amyotrophic lateral sclerosis. Trends Pharmacol. Sci. 18, 196±203.
to cells using a multibarrel local perfusion pipette with a common MacIver, M.B., Amagasu, S.M., Mikulec, A.A., and Monroe, F.A.
delivery port. (1996). Riluzole anesthesia: use-dependent block of presynaptic
glutamate fibers. Anesthesiology 85, 626±634.
Acknowledgments Mackenzie, P.J., and Murphy, T.H. (1998). High safety factor for
action potential conduction along axons but not dendrites of cul-
The authors thank Joel Springer (University of Kentucky), members tured hippocampal and cortical neurons. J. Neurophysiol. 80, 2089±
of the Zorumski Laboratory, Peter Lukasiewicz, Kel Yamada, Liu Lin 2101.
Thio (Washington University), and Jack Waters (Stanford University) Magee, J.C., and Johnston, D. (1995). Synaptic activation of voltage-
for valuable discussions and Ann Benz for preparation of hippocam- gated channels in the dendrites of hippocampal pyramidal neurons.
pal cultures. The authors are especially indebted to Chuck Zorumski Science 268, 301±304.
for generous financial and intellectual support. This work was sup-
Magleby, K.L. (1987). Short-term changes in synaptic efficacy. In
ported by a National Alliance for Research on Schizophrenia and Synaptic Function, G.M. Edelman et al., eds. (New York: John Wiley
Depression Young Investigator Award (S. M.) and National Institutes and Sons), pp. 13±31.
of Health grant MH45493.
Martin, D., Thompson, M.A., and Nadler, J.V. (1993). The neuropro-
tective agent riluzole inhibits release of glutamate and aspartate
Received December 21, 1999; revised April 13, 2000. from slices of hippocampal area CA1. Eur. J. Pharmacol. 250,
473±476.
References Martina, M., and Jonas, P. (1997). Functional differences in Na1
channel gating between fast-spiking interneurones and principal
Atwood, H.L. (1967). Variation in physiological properties of crusta- neurones of rat hippocampus. J. Physiol. (Lond) 505, 593±603.
cean motor synapses. Nature 215, 57±58. Martina, M., Vida, I., and Jonas, P. (2000). Distal initiation and active
Bekkers, J.M., and Stevens, C.F. (1991). Excitatory and inhibitory propagation of action potentials in interneuron dendrites. Science
autaptic currents in isolated hippocampal neurons maintained in 287, 295±300.
cell culture. Proc. Natl. Acad. Sci. USA 88, 7834±7838. Mennerick, S., and Zorumski, C.F. (1995). Paired-pulse modulation
Colbert, C.M., and Johnston, D. (1996). Axonal action-potential initi- of fast excitatory synaptic currents in microcultures of rat hippocam-
ation and Na1 channel densities in the soma and axon initial segment pal neurons. J. Physiol. (Lond) 488, 85±101.
of subicular pyramidal neurons. J. Neurosci. 16, 6676±6686. Mennerick, S., Que, J., Benz, A., and Zorumski, C.F. (1995). Passive
Debono, M.W., Le Guern, J., Canton, T., Doble, A., and Pradier, and synaptic properties of neurons grown in microcultures and in
mass cultures. J. Neurophysiol. 73, 320±332.L. (1993). Inhibition by riluzole of electrophysiological responses
Neuron
682
Msghina, M., Govind, C.K., and Atwood, H.L. (1998). Synaptic struc-
ture and transmitter release in crustacean phasic and tonic motor
neurons. J. Neurosci. 18, 1374±1382.
Msghina, M., Millar, A.G., Charlton, M.P., Govind, C.K., and Atwood,
H.L. (1999). Calcium entry related to active zones and differences
in transmitter release at phasic and tonic synapses. J. Neurosci. 19,
8419±8434.
Murthy, V.N., Sejnowski, T.J., and Stevens, C.F. (1997). Heteroge-
neous release properties of visualized individual hippocampal syn-
apses. Neuron 18, 599±612.
Obrenovitch, T.P. (1998). Amyotrophic lateral sclerosis, excitotox-
icity and riluzole. Trends Pharmacol. Sci. 19, 9±11.
Rosenmund, C., Clements, J.D., and Westbrook, G.L. (1993). Non-
uniform probability of glutamate release at a hippocampal synapse.
Science 262, 754±757.
Sather, W., Dieudonne, S., MacDonald, J.F., and Ascher, P. (1992).
Activation and desensitization of N-methyl-D-aspartate receptors
in nucleated outside-out patches from mouse neurones. J. Physiol.
(Lond) 450, 643±672.
Schikorski, T., and Stevens, C.F. (1997). Quantitative ultrastructural
analysis of hippocampal excitatory synapses. J. Neurosci. 17, 5858±
5867.
Song, J.H., Huang, C.S., Nagata, K., Yeh, J.Z., and Narahashi, T.
(1997). Differential action of riluzole on tetrodotoxin-sensitive and
tetrodotoxin-resistant sodium channels. J. Pharmacol. Exp. Ther.
282, 707±714.
Stefani, A., Spadoni, F., and Bernardi, G. (1997). Differential inhibition
by riluzole, lamotrigine, and phenytoin of sodium and calcium cur-
rents in cortical neurons: implications for neuroprotective strategies.
Exp. Neurol. 147, 115±122.
Stuart, G.J., and Sakmann, B. (1994). Active propagation of somatic
action potentials into neocortical pyramidal cell dendrites. Nature
367, 69±72.
Stuart, G., Spruston, N., Sakmann, B., and Hausser, M. (1997). Action
potential initiation and backpropagation in neurons of the mamma-
lian CNS. Trends Neurosci. 20, 125±131.
Taylor, C.P., and Meldrum, B.S. (1995). Na1 channels as targets for
neuroprotective drugs. Trends Pharmacol. Sci. 16, 309±316.
Umemiya, M., and Berger, A.J. (1995). Inhibition by riluzole of gly-
cinergic postsynaptic currents in rat hypoglossal motoneurones. Br.
J. Pharmacol. 116, 3227±3230.
Zucker, R.S. (1989). Short-term synaptic plasticity. Annu. Rev. Neu-
rosci. 12, 13±31.
